OBJECTIVES: To investigate the temporal trend in the national incidence of bronchiolitis
hospitalizations, their characteristics, inpatient resource use, and hospital cost from 2000 …

Platelets are essential mediators of inflammation and thrombosis. Chronic obstructive
pulmonary disease (COPD) is a heterogeneous multisystem disease, causing significant …

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently coexist but combined disease is often not recognised. Since symptoms overlap …

Background There is a lack of comprehensive view of the association between acute
exacerbation of COPD (AECOPD) and the risk of acute cardiovascular events. Objective To …

Aims To evaluate the impact of chronic obstructive pulmonary disease (COPD) on 10-year
all-cause death and the treatment effect of CABG versus PCI on 10-year all-cause death in …

Background Aspirin use in COPD has been associated with reduced all-cause mortality in
meta-regression analysis with few equivocal studies. However, the effect of aspirin on COPD …

Introduction: Antiplatelet therapy has been associated with fewer exacerbations and
reduced respiratory symptoms in chronic obstructive pulmonary disease (COPD). Whether …

Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of acute
cardiovascular events, and around 30% die from cardiovascular diseases. Recent data …

Chronic inflammation exerts pleiotropic effects in the aetiology and progression of chronic
obstructive pulmonary disease (COPD). Glucosamine is widely used in many countries and …

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently coexist, increasing the prevalence of both entities and impacting on symptoms …